Which Inhibitor of the Renin–Angiotensin System Should Be Used in Chronic Heart Failure and Acute Myocardial Infarction?
- 16 November 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (20), 3281-3288
- https://doi.org/10.1161/01.cir.0000147274.83071.68
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Angiotensin AT 2 Receptors Directly Stimulate Renal Nitric Oxide in Bradykinin B 2 -Receptor–Null MiceHypertension, 2003
- Sustained Reduction of Aldosterone in Response to the Angiotensin Receptor Blocker Valsartan in Patients With Chronic Heart FailureCirculation, 2003
- Interaction of -blockers and angiotensin receptor blockers/ACE inhibitors in heart failureJournal of the Renin-Angiotensin-Aldosterone System, 2003
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Review: Prospects for ARB in the next five yearsJournal of the Renin-Angiotensin-Aldosterone System, 2001
- Points to consider on switching between superiority and non‐inferiorityBritish Journal of Clinical Pharmacology, 2001
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Increased Vasoconstrictor Response of the Mouse Lacking Angiotensin II Type 2 ReceptorBiochemical and Biophysical Research Communications, 1999
- Neuroendocrine activation after acute myocardial infarction.Heart, 1988